Altogether, our study identified a mechanism by which tumours, through Upd3 or IL-6 signalling, induce hepatic gluconeogenesis independently of the Cori cycle, highlighting a direct influence of tumour-derived factors on hepatic glucose metabolism. This evidence concerns the gene IL6 and neoplasm.